Skip to main content
Indian Journal of Clinical Biochemistry logoLink to Indian Journal of Clinical Biochemistry
. 2002 Jul;17(2):7–26. doi: 10.1007/BF02867967

HPLC method for amino acids profile in biological fluids and inborn metabolic disorders of aminoacidopathies

S V Suresh Babu 1, M M Shareef 1, A Pavan Kumar Shetty 1, K Taranath Shetty 1,
PMCID: PMC3454125  PMID: 23105346

Abstract

Quantification of total and individual amino acids in biological fluids such as plasma, urine and cerebrospinal fluid has an important diagnostic implication in laboratory medicine. The present paper describes protocols for the assay of total amino acids by modified method based on dinitrophenyl and HPLC profile involving pre-column derivatization with o-pthalaldehyde (OPA) derivatization, respectively. The method, based on the alkylation of-SH groups prior to OPA derivatization of amino acids followed by reverse phase high performance liquid chromatography, provide a comprehensive profile of more than twenty amino acids (including-SH group containing) in a single run lasting about 45 minutes. The present study, apart from establishing the normal profile of amino acids in plasma of Indian sub population, also presents HPLC profile for some of the rare amino acidopathies.

Key words: O-pthaladehyde, amino acidopathies, amino acids profile, reverse phase HPLC, Inborn metabolic disorders

Full Text

The Full Text of this article is available as a PDF (913.5 KB).

References

  • 1.Walker V, Mills G. A. Quantitative methods for amino acid analysis in biological fluids. Ann. Clin. Biochem. 1995;32:28–57. doi: 10.1177/000456329503200103. [DOI] [PubMed] [Google Scholar]
  • 2.Andersson A., Isaksson A., Bratstrom L, Bjorn H. Homocysteine and other thiols in plasma and thiol specific postcolumn derivatization. Clin. Chem. 1993;39:1590–1597. [PubMed] [Google Scholar]
  • 3.Deyl Z., Hyanek J, Horakova M. Profiling of amino acids in body fluids and tissues by means of liquid chromatography. J. Chromatogr. 1986;379:177–250. doi: 10.1016/S0378-4347(00)80685-4. [DOI] [PubMed] [Google Scholar]
  • 4.Jacobsen D. W. Homocysteine and vitamins in cardiovascular disease. Clin. Chem. 1998;44:1833–1843. [PubMed] [Google Scholar]
  • 5.Hankey G. J, Eikelboom J. W. Homocysteine and vascular disease. The Lancet. 1999;354:407–413. doi: 10.1016/S0140-6736(98)11058-9. [DOI] [PubMed] [Google Scholar]
  • 6.Welch G. N, Loscalzo J. Homocysteine and atherothrombosis. New Engl. J. Med. 1998;338:1042–1050. doi: 10.1056/NEJM199804093381507. [DOI] [PubMed] [Google Scholar]
  • 7.Boushey C. J., Beresford S. A. A., Omen G. S., Motulsky A. G. A quantitative assessment of plasma homocysteine as a risk factor in vascular disease. JAMA. 1995;274:1049–1057. doi: 10.1001/jama.274.13.1049. [DOI] [PubMed] [Google Scholar]
  • 8.Graham I. M., Daly L. E., Refsum H. M., Robinson K., Brattstrom L. E., Ueland Per M., Palma-Reis R. J., Boers G. H., Sheahan R. G., Israelsson Bo., Uiterwaal. C. S., Meleady R., McMaster D., Verhoef P., Witterman J., Rubba P., Bellet H., Wutreccht J. C., deWalk H. W., Luis C. S., Parrot-Rouland F. M., Tan K. S., Higgins I., Garcon D., Medrano M. J., Candito M., Evans A. E., Andria G. Plasma homocysteine as a risk factor for vascular disease: European concerted action project. JAMA. 1997;277:1775–1781. doi: 10.1001/jama.277.22.1775. [DOI] [PubMed] [Google Scholar]
  • 9.Frantzen F., Faaren A. L., Alfheim I, Nordhei A. K. Enzyme conversion immuno assay for determining total homocysteine in plasma or serum. Clin. Chem. 1998;44:311–316. [PubMed] [Google Scholar]
  • 10.Refsum H., Ueland P. M., Svardal A. M. Fully automated fluorescence assay for determining total homocysteine in plasma. Clin. Chem. 1989;35:1921–1927. [PubMed] [Google Scholar]
  • 11.Robenstein D. L., Yamaahita G. T. Determination of homocysteine, penicillamine and their symmetrical and mixed disulfides by liquid chromatography with electrochemical detection. Anal. Biochem. 1989;80:259–263. doi: 10.1016/0003-2697(89)90427-2. [DOI] [PubMed] [Google Scholar]
  • 12.Thomson S. B, Tucker D. J. Determination of homocysteine in urine. J. Chromatogr. 1985;338:201–208. doi: 10.1016/0378-4347(85)80086-4. [DOI] [PubMed] [Google Scholar]
  • 13.Pastore A., Massoud R., Motti C., Russo A. Lo., Fucci G., Cortese C, Federici G. Fully automated assay for total homocysteine, cysteine, cysteinylglycine, glutathione, cysteamine and 2-mercaptopropionylglycine in plasma and urine. Cin. Chem. 1998;44:825–832. [PubMed] [Google Scholar]
  • 14.Mansoor M. A., Svardal A M, Ueland P. M. Determination of thein vivo redox status of cysteine, cysteinylglycine, homocysteine and glutathione in human plasma. Anal. Biochem. 1992;200:218–229. doi: 10.1016/0003-2697(92)90456-H. [DOI] [PubMed] [Google Scholar]
  • 15.Hyland K., Bottiglieri T. Measurement of total plasma and cerebrospinal fluid homocysteine by fluorescence following high performance liquid chromatography and pre column derivatization with opthalaldehyde. J. Chromatogr. 1992;579:55–62. doi: 10.1016/0378-4347(92)80362-T. [DOI] [PubMed] [Google Scholar]
  • 16.Bradford M. A rapid and sensitive method for the quantification of micrograms quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 1976;76:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  • 17.Varley H., Gowenlock A. H., Bell M. Practical Clinical Biochemistry. Vol I. Fifth edn. London: William Heinemann Medical Books Lts; 1980. pp. 491–494. [Google Scholar]
  • 18.Turnell D. C., Cooper J. D. H. Rapid assay for amino acids in serum or urine by precolumn derivatization and reversed phase liquid chromatography. Clin. Chem. 1982;28:527–531. [PubMed] [Google Scholar]
  • 19.Teerlink Tom, Paul A. M., Leeuwen, Alexander H. Plasma amino acids determined by liquid chromatography within 17 minutes. Clin. Chem. 1994;40:245–249. [PubMed] [Google Scholar]
  • 20.Hamesh A, Jhonson M. W. Nonketotic hyperglycinemia. In: Scriver C.R., Beaudet A.I., Sly W.S, Valle D., editors. The Metabolic & Molecular Bases of inherited Diseases. Eight edition. New York: McGraw Hill Med Publication Division; 2001. pp. 2065–2078. [Google Scholar]
  • 21.Valle D, Simell O. The hyperornithinemias. In: Scriver C.R., Beaudet A.I., Sly W.S, Valle D., editors. The Metabolic & Molecular Bases of inherited Diseases. Eighth edition. New York: McGraw Hill Med Publication Division; 2001. pp. 1857–1895. [Google Scholar]
  • 22.Chung D. T., Shih V. E. Maple syrup urine disease (Branched chain ketoaciduria) In: Scriver C.R., Beaudet A.I., Sly W.S, Valle D., editors. The Metabolic & Molecular Bases of inherited Diseases. eight edition. New York: McGraw Hill Med Publication Division; 2001. pp. 1971–2005. [Google Scholar]
  • 23.Mudd S. H., Levy H. L., Kraus J. P. Disorders of transulfuration. In: Scriver C.R., Beaudet A.I., Sly W.S, Valle D., editors. The Metabolic & Molecular Bases of inherited Diseases. eight edition. New York: Mcgraw Hill Med Publication Division; 2001. pp. 2007–2056. [Google Scholar]

Articles from Indian Journal of Clinical Biochemistry are provided here courtesy of Springer

RESOURCES